Literature DB >> 27834000

The natural course of idiopathic epiretinal membranes with optical coherence tomography follow-up.

Ahmet Taylan Yazıcı1, Osman Çekiç2.   

Abstract

Mesh:

Year:  2016        PMID: 27834000     DOI: 10.1007/s00417-016-3479-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Retinal thickness change in relation to visual acuity improvement after 23-gauge vitrectomy for idiopathic epimacular membrane.

Authors:  Ö Çekiç; M Cakır; N Alagöz; O F Yılmaz
Journal:  Eye (Lond)       Date:  2010-11-26       Impact factor: 3.775

2.  Objective signs of photoreceptor displacement by binocular correspondence perimetry: a study of epiretinal membranes.

Authors:  Kristian Krøyer; Ole Mark Jensen; Michael Larsen
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

3.  Idiopathic and secondary epiretinal membranes: do they differ in terms of morphology? An optical coherence tomography-based study.

Authors:  Ahmet T Yazici; Neşe Alagöz; Haci U Celik; Ercüment Bozkurt; Cengiz Alagöz; Mehmet Cakir; Osman Cekiç; Omer F Yilmaz
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

4.  Correlation between visual acuity changes and optical coherence tomography morphological findings in idiopathic epiretinal membranes.

Authors:  I-Mo Fang; Chih-Chao Hsu; Li-Li Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-29       Impact factor: 3.117

5.  Comparison of photoreceptor outer segment length in diabetic and idiopathic epiretinal membranes.

Authors:  K Yüksel; Y Karaküçük; A Özkaya; G Pekel; Ö Baz; C Alagöz; A T Yazıcı
Journal:  Eye (Lond)       Date:  2015-07-17       Impact factor: 3.775

6.  Incidence and progression of epiretinal membranes in eyes after cataract surgery.

Authors:  Calvin Sze-Un Fong; Paul Mitchell; Elena Rochtchina; Thomas Hong; Tania de Loryn; Jie Jin Wang
Journal:  Am J Ophthalmol       Date:  2013-04-26       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.